Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

Inclusion Criteria: * Have a clinical diagnosis of blepharoconjunctivitis * Must be willing to discontinue contact lens wear for the duration of the study * Have best corrected visual acuity of 6/24 in both eyes * Have IOP less than or equal to 25 mmHg in either eye Exclusion Criteria: * Have known sensitivity or poor tolerance to any component of the study medications * Have a history of eyelid and/or ocular surgery and/or have had ocular surgical intervention within 6 months prior to visit 1 or during the study and/or a history of refractive surgery within 6 months * Have worn contact lenses 72 hours prior to visit 1 and/or need to wear contact lenses for the duration of the study * Have used any topical ophthalmic solutions including tear substitutes within 2 hours of enrollment * Use of any eye make-up during the study * Have any uncontrolled systemic disease or debilitating disease * Have been diagnosed with glaucoma * Have any clinically significant cardiovascular disorders * Have any history of liver or kidney disease resulting in persisting dysfunction * Have prior (within 30 days of beginning study treatment) or anticipated concurrent use of an investigational drug or device